Report cover image

mRNA: Therapeutics and Global Markets

Publisher BCC Research
Published Dec 13, 2023
Length 171 Pages
SKU # WA18381953

Description

mRNA: Therapeutics and Global Markets



Report Scope:

This report focuses on the mRNA therapeutics market. This reports include the types of mRNA and their application in therapy. Also, the report focuses on the patent analysis and clinical trial analysis of mRNA. The report also portrays the trends and dynamics affecting the market during the study period. The study covers market projections through 2028 and profiles major market players.

By geography, the market is segregated into North America, Europe, Asia-Pacific and the Rest of the World (RoW). The market is estimated through 2028.

BCC Research also summarizes the main industry acquisitions and strategic alliances from January 2020 through December 2022 and identifies the trends in this activity.

Report Includes:

37 data tables and 27 additional tables

An overview of the global market related to mRNA therapeutics

In-depth analysis of global market trends, featuring historical revenue data for 2021 and 2022, estimated figures for 2023, forecasts for 2028, and projections of compound annual growth rates (CAGRs) through 2028

Evaluation of the current market and revenue growth prospects specific to mRNA therapeutics, accompanied by a market share analysis by therapeutic type and geographical region

Coverage of the pandemic threats, therapeutic developments, and new technologies in the market

Discussion of the advantages of mRNA over proteinand DNA-based delivery systems, demographic and economic trends, and outlook for the mRNA therapeutics market

Information on prophylactic vaccines, vaccine discovery and development, and R&D activities

Analysis of the various therapeutics as well as promising vaccines intended for the prevention and treatment of chronic and infectious diseases

Assessment of regulatory structure, pricing and reimbursement scenarios, the pipeline for new molecules and therapeutics

Market share analysis of the key companies and mergers & acquisitions, joint ventures, collaborations, and partnerships

Profiles of leading market participants

Companies Mentioned

BioNTech SE
MERCK KGAA
Moderna Inc.
NUTCRACKER THERAPEUTICS
STRAND THERAPEUTICS

Table of Contents

171 Pages
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in This Update?
Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown
Chapter 2 Summary and Highlights
Market Outlook
Market Summary
Chapter 3 Market Overview
Evolution of RNA Therapeutics
History of RNA Therapeutics
Development of RNA Therapeutics and Types
DNA Therapeutics vs. RNA Therapeutics
Clinical Need for RNA Therapeutics
Increasing Disease Population and Economic Burden
Limitations of Traditional Therapeutics
Therapeutic Limitations of Biologics
Poor Management of Chronic Diseases
Limited Treatment for Rare Diseases
RNA Therapeutics
Antisense Oligonucleotide (ASO) as Therapeutics
Small Interfering RNA (siRNA) as Therapeutics
miRNA as Therapeutics
Aptamers as Therapeutics
mRNA as Therapeutics
Manufacturing RNA-Based Biopharmaceuticals
Chromatographic Purification Steps
Delivery of RNA Therapeutics
Polymer Conjugation/Chemical Modification
Encapsulation
Lipid-Based Nanoparticles
Polymer Nanomaterials
Silica Nanoparticles
Carbon and Gold Nanomaterials
GalNAc
Institution and Hospital-Based RNA Therapeutics
Regulatory Influence on the Market for RNA Therapeutics
Impact of COVID-19
Chapter 4 Market Dynamics
Market Dynamics
Drivers
Restraints
Opportunities
Chapter 5 Target Disease and Disorders
Overview of Common Diseases and Disorders for mRNA Therapeutics
Cancer
Infectious Diseases
Cardiovascular Disease
Lifestyle Disorders
Respiratory Disorders
Musculoskeletal Disorders
Gastrointestinal Disorders
Urology Disorders
Nephrology Disorders
Immune Disorders
Neurological Disorders
Rare Diseases
Other Disorders
Tobacco Smoking and Associated Diseases
Infectious Diseases: COVID-19 Pandemic and mRNA Therapeutics
Chronic Diseases: Expanding Horizon for mRNA Therapeutics
Unmet Needs of Rare Diseases: mRNA Therapeutics
Aging, Gender and Onset of Diseases
Global Demographics
U.S. Demographics
European Demographics
Japanese Demographics
Chapter 6 Pipeline and Clinical Trial Analysis
mRNA Vaccines
mRNA Therapeutics
Clinical Trial Analysis
Chapter 7 Market Breakdown by Product
Mechanism of Action of mRNA COVID Vaccines
Three Most-Advanced mRNA Vaccines
Chapter 8 Market Breakdown by Region
North America
Canada
Europe
Asia-Pacific
Japan
South Korea
China
India
Australia
RoW
Chapter 9 Emerging Technologies and Developments
Overview
Nanoparticles
Modified mRNA
Automated mRNA Synthesis Kits
Bio Platforms
Chapter 10 Patent Analysis
Patent Analysis
mRNA Publication
Chapter 11 Outlook for Mergers & Acquisitions, and Venture Funding
Chapter 12 Competitive Intelligence
Chapter 13 Company Profiles
ARCTUR U.S. THERAPEUTICS INC.
BIONTECH SE
CUREVAC N.V.
GENNOVA BIOPHARMACEUTICALS LTD.
MERCK KGAA
MODERNA INC.
NUTCRACKER THERAPEUTICS
OMEGA THERAPEUTICS INC.
STRAND THERAPEUTICS
VAXESS TECHNOLOGIES INC.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us